Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Kurt Roth
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Chemicals & Drugs
Disorders
Procedures
Concepts & Ideas
Physiology
Geographic Areas
Sign-in to see full Profile
Network (preview)
35
Zeuzem, Stefan
24
Seifried, Erhard
16
Rüster, Brigitte
15
Schmidt, Michael
13
Hourfar, Michael
11
Lee, Jung-Hun
8
Drosten, Christian
8
Sarrazin, Christoph
6
Raedle, Jochen
6
Teuber, Gerlinde
5
Chudy, Michael
5
Kronenberger, Bernd
4
Nübling, Micha
4
Oremek, Gerhard
4
Lee, JH
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Kurt Roth (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Drexler Jan Felix; Kupfer Bernd; Petersen Nadine; Grotto Rejane Maria Tommasini; Rodrigues Silvia Maria Corvino; Grywna Klaus; Panning Marcus; Annan Augustina; Silva Giovanni Faria; Douglas Jill; Koay Evelyn S C; Smuts Heidi; Netto Eduardo M; Simmonds Peter; Pardini Maria Inês de Moura Campos; Roth W Kurt; Drosten Christian
A novel diagnostic target in the hepatitis C virus genome.
PLoS medicine 2009;6(2):e31.
-
2008: Hourfar Michael K; Jork Christine; Schottstedt Volkmar; Weber-Schehl Marijke; Brixner Veronika; Busch Michael P; Geusendam Geert; Gubbe Knut; Mahnhardt Christina; Mayr-Wohlfart Uschi; Pichl Lutz; Roth W Kurt; Schmidt Michael; Seifried Erhard; Wright David J;
Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Transfusion 2008;48(8):1558-66.
-
2008: Pfleiderer Christa; Blümel Johannes; Schmidt Michael; Roth W Kurth; Houfar M Kai; Eckert Jana; Chudy Michael; Menichetti Eva; Lechner Sigrid; Nübling C Micha
West Nile virus and blood product safety in Germany.
Journal of medical virology 2008;80(3):557-63.
-
2007: Hourfar M K; Koller M; Roth W K; Kehrli R; Seifried E; Schmidt M
Balance module allows consistent monitoring and documentation of the pooling process for nucleic acid amplification technology testing.
Vox sanguinis 2007;93(1):37-41.
-
2006: Schmidt M; Nübling C M; Scheiblauer H; Chudy M; Walch L A; Seifried E; Roth W K; Hourfar M K
Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.
Vox sanguinis 2006;91(3):237-43.
-
2006: Schmidt Michael; Hourfar Michael K; Nicol Sven-Boris; Wahl Alexandra; Heck Julia; Weis Christina; Tonn Torsten; Spengler Hans-Peter; Montag Thomas; Seifried Erhard; Roth W Kurt
A comparison of three rapid bacterial detection methods under simulated real-life conditions.
Transfusion 2006;46(8):1367-73.
-
2006: Chudy Michael; Schmidt Michael; Czudai Volker; Scheiblauer Heinrich; Nick Sigrid; Mosebach Mira; Hourfar Michael Kai; Seifried Erhard; Roth W Kurt; Grünelt Elke; Nübling C Micha
Hepatitis B virus genotype G monoinfection and its transmission by blood components.
Hepatology (Baltimore, Md.) 2006;44(1):99-107.
-
2006: Schmidt M; Hourfar M K; Wahl A; Nicol S-B; Montag T; Roth W K; Seifried E
Fluorescence quencher improves SCANSYSTEM for rapid bacterial detection.
Vox sanguinis 2006;90(4):276-8.
-
2006: Schmidt M; Roth W K; Seifried E; Hourfar M K
Donor screening for agents of bioterror.
Transfusion 2006;46(4):678; author reply 678-9.
-
2006: Pfleiderer C; König C; Chudy M; Schmidt M; Roth W K; Nübling C M
Molecular epidemiology of West Nile Virus in humans.
Developments in biologicals 2006;126():197-201; discussion 326-7.
-
2005: Schmidt Michael; Weis Christina; Heck Julia; Montag Thomas; Nicol Sven-Boris; Hourfar Michael K; Schaefer Volker; Sireis Walid; Roth W Kurt; Seifried Erhard
Optimized Scansystem platelet kit for bacterial detection with enhanced sensitivity: detection within 24 h after spiking.
Vox sanguinis 2005;89(3):135-9.
-
2005: Hourfar M K; Schmidt M; Seifried E; Roth W K
Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment.
Vox sanguinis 2005;89(2):71-6.
-
2005: Hourfar Michael K; Michelsen Uwe; Schmidt Michael; Berger Annemarie; Seifried Erhard; Roth W Kurt
High-throughput purification of viral RNA based on novel aqueous chemistry for nucleic acid isolation.
Clinical chemistry 2005;51(7):1217-22.
-
2005: Schmidt Michael; Weber Marijke; Busch Michael P; Tobler Leslie H; Phelps Bruce H; Seifried Erhard; Roth W Kurt
Yield of hepatitis C virus nucleic acid testing among antibody-reactive or confirmed-positive samples.
Transfusion 2005;45(6):1040-2.
-
2005: Schmidt Michael; Roth W Kurt; Meyer Hermann; Seifried Erhard; Hourfar Michael K
Nucleic acid test screening of blood donors for orthopoxviruses can potentially prevent dispersion of viral agents in case of bioterrorism.
Transfusion 2005;45(3):399-403.
-
2004: Hourfar Michael K; Roth W Kurt; Seifried Erhard; Schmidt Michael
Comparison of two real-time quantitative assays for detection of severe acute respiratory syndrome coronavirus.
Journal of clinical microbiology 2004;42(5):2094-100.
-
2004: Schmidt Michael; Brixner Veronika; Ruster Brigitte; Hourfar Michael K; Drosten Christian; Preiser Wolfgang; Seifried Erhard; Roth W Kurt
NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions.
Transfusion 2004;44(4):470-5.
-
2004: Seifried Carola; Weber Marijke; Bialleck Heike; Seifried Erhard; Schrezenmeier Hubert; Roth W Kurt
High prevalence of GBV-C/HGV among relatives of GBV-C/HGV-positive blood donors in blood recipients and in patients with aplastic anemia.
Transfusion 2004;44(2):268-74.
-
2004: Drosten Christian; Nippraschk Thomas; Manegold Christoph; Meisel Helga; Brixner Veronika; Roth W Kurt; Apedjinou Anani; Günther Stephan
Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;29(1):59-68.
-
2003: Chudy Michael; Hewlett Indira; Saldanha John; Bianco Celso; Conrad Andrew J; Gierman Todd; Heldebrant Charles; Rautmann Guy G; Roth W Kurt; Stramer Susan; Weimer Thomas; Whitaker Barbee; Zerlauth Gerold;
Technical considerations for the performance of Nucleic acid Amplification Technology (NAT). The NAT Task Force Group.
Biologicals : journal of the International Association of Biological Standardization 2003;31(3):153-9.
-
2003: Klein Stefan A; Karsten Susanne; Rüster Brigitte; Klebba Christian; Pape Martine; Ottmann Oliver G; Hoelzer Dieter; Roth Willi K
Comparison of TaqMan real-time PCR and p24 Elisa for quantification of in vitro HIV-1 replication.
Journal of virological methods 2003;107(2):169-75.
-
2002: Roth W K; Seifried E
The German experience with NAT.
Transfusion medicine (Oxford, England) 2002;12(4):255-8.
-
2002: Roth W Kurt; Weber Marijke; Petersen Detlev; Drosten Christian; Buhr Sylvia; Sireis Walid; Weichert Wolfgang; Hedges Doris; Seifried Erhard
NAT for HBV and anti-HBc testing increase blood safety.
Transfusion 2002;42(7):869-75.
-
2002: Roth W Kurt; Weber Marijke; Buhr Sylvia; Drosten Christian; Weichert Wolfgang; Sireis Walid; Hedges Doris; Seifried Erhard
Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe.
Transfusion 2002;42(7):862-8.
-
2001: Drosten C; Seifried E; Roth W K
TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening.
Journal of clinical microbiology 2001;39(12):4302-8.
-
2001: Sarrazin C; Bruckner M; Herrmann E; Rüster B; Bruch K; Roth W K; Zeuzem S
Quasispecies heterogeneity of the carboxy-terminal part of the E2 gene including the PePHD and sensitivity of hepatitis C virus 1b isolates to antiviral therapy.
Virology 2001;289(1):150-63.
-
2001: Roth W K; Seifried E
Yield and future issues of nucleic acid testing.
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2001;8(3):282-4.
-
2001: Kronenberger B; Rüster B; Elez R; Weber S; Piiper A; Lee J H; Roth W K; Zeuzem S
Interferon alfa down-regulates CD81 in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2001;33(6):1518-26.
-
2001: Zeuzem S; Herrmann E; Lee J H; Fricke J; Neumann A U; Modi M; Colucci G; Roth W K
Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a.
Gastroenterology 2001;120(6):1438-47.
-
2001: Rüster B; Zeuzem S; Krump-Konvalinkova V; Berg T; Jonas S; Severin K; Roth W K
Comparative sequence analysis of the core- and NS5-region of hepatitis C virus from tumor and adjacent non-tumor tissue.
Journal of medical virology 2001;63(2):128-34.
-
2000: Kronenberger B; Rüster B; Lee J H; Sarrazin C; Roth W K; Herrmann G; Zeuzem S
Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels.
Journal of hepatology 2000;33(4):640-7.
-
2000: Sarrazin C; Rüster B; Lee J H; Kronenberger B; Roth W K; Zeuzem S
Prospective follow-up of patients with GBV-C/HGV infection: specific mutational patterns, clinical outcome, and genetic diversity.
Journal of medical virology 2000;62(2):191-8.
-
2000: Drosten C; Weber M; Seifried E; Roth W K
Evaluation of a new PCR assay with competitive internal control sequence for blood donor screening.
Transfusion 2000;40(6):718-24.
-
2000: Sarrazin C; Kornetzky I; Rüster B; Lee J H; Kronenberger B; Bruch K; Roth W K; Zeuzem S
Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3a and correlation with treatment response.
Hepatology (Baltimore, Md.) 2000;31(6):1360-70.
-
2000: Lee J H; Teuber G; von Wagner M; Roth W K; Zeuzem S
Antiviral effect of human recombinant interleukin-12 in patients infected with hepatitis C virus.
Journal of medical virology 2000;60(3):264-8.
-
2000: Sarrazin C; Berg T; Lee J H; Rüster B; Kronenberger B; Roth W K; Zeuzem S
Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response.
The Journal of infectious diseases 2000;181(2):432-41.
-
2000: Roth W K; Buhr S; Drosten C; Seifried E
NAT and viral safety in blood transfusion.
Vox sanguinis 2000;78 Suppl 2():257-9.
-
1999: Brieger A; Trojan J; Raedle J; Roth W K; Zeuzem S
Identification of germline mutations in hereditary nonpolyposis colorectal cancer using base excision sequence scanning analysis.
Clinical chemistry 1999;45(9):1564-7.
-
1999: Giannini C D; Roth W K; Piiper A; Zeuzem S
Enzymatic and antisense effects of a specific anti-Ki-ras ribozyme in vitro and in cell culture.
Nucleic acids research 1999;27(13):2737-44.
-
1999: Sarrazin C; Berg T; Lee J H; Teuber G; Dietrich C F; Roth W K; Zeuzem S
Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type 1b undergoing combination therapy.
Journal of hepatology 1999;30(6):1004-13.
-
1999: Roth W K; Weber M; Seifried E
Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.
Lancet 1999;353(9150):359-63.
-
1999: Trojan J; Brieger A; Raedle J; Roth W K; Zeuzem S
Peutz-Jeghers syndrome: molecular analysis of a three-generation kindred with a novel defect in the serine threonine kinase gene STK11.
The American journal of gastroenterology 1999;94(1):257-61.
-
1998: Sarrazin C; Roth W K; Zeuzem S
[GB virus-C/hepatitis G virus--discovery, epidemiology, diagnosis and clinical relevance]
Zeitschrift für Gastroenterologie 1998;36(11):997-1008.
-
1998: Raedle J; Oremek G; Truschnowitsch M; Lorenz M; Roth W K; Caspary W F; Zeuzem S
Clinical evaluation of autoantibodies to p53 protein in patients with chronic liver disease and hepatocellular carcinoma.
European journal of cancer (Oxford, England : 1990) 1998;34(8):1198-203.
-
1998: Lee J H; von Wagner M; Roth W K; Teuber G; Sarrazin C; Zeuzem S
Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus.
Journal of hepatology 1998;29(1):29-35.
-
1998: Zeuzem S; Schmidt J M; Lee J H; von Wagner M; Teuber G; Roth W K
Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
Hepatology (Baltimore, Md.) 1998;28(1):245-52.
-
1998: Zeuzem S; Lee J H; Franke A; Rüster B; Prümmer O; Herrmann G; Roth W K
Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa.
Hepatology (Baltimore, Md.) 1998;27(4):1149-56.
-
1998: Roth W K; Lee J H; Rüster B; Zeuzem S
Quantification of hepatitis C virus RNA by RT-PCR in comparison to the branched DNA method.
Zeitschrift für Gastroenterologie 1998;36(1):5-11.
-
1997: Sarrazin C; Roth W K; Zeuzem S
Heterosexual transmission of GB virus-C/hepatitis G virus infection.
European journal of gastroenterology & hepatology 1997;9(11):1117-20.
-
1997: Lee J H; Stripf T; Roth W K; Zeuzem S
Non-isotopic detection of hepatitis C virus quasispecies by single strand conformation polymorphism.
Journal of medical virology 1997;53(3):245-51.
-
1997: Zeuzem S; de Man R A; Honkoop P; Roth W K; Schalm S W; Schmidt J M
Dynamics of hepatitis B virus infection in vivo.
Journal of hepatology 1997;27(3):431-6.
-
1997: Sarrazin C; Herrmann G; Roth W K; Lee J H; Marx S; Zeuzem S
Prevalence and clinical and histological manifestation of hepatitis G/GBV-C infections in patients with elevated aminotransferases of unknown etiology.
Journal of hepatology 1997;27(2):276-83.
-
1997: Dietrich C F; Lee J H; Herrmann G; Teuber G; Roth W K; Caspary W F; Zeuzem S
Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 1997;26(2):467-72.
-
1997: Raedle J; Oremek G; Roth W K; Caspary W F; Zeuzem S
Anti-p53 autoantibodies in hepatitis C virus-infected patients.
Anticancer research 1997;17(4B):3079-81.
-
1997: Roth W K; Waschk D; Marx S; Tschauder S; Zeuzem S; Bialleck H; Weber H; Seifried E
Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients.
Transfusion 1997;37(6):651-6.
-
1997: Lee J H; Roth W K; Zeuzem S
Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays.
Journal of hepatology 1997;26(5):1001-9.
-
1997: Zeuzem S; Lee J H; Roth W K
Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
Hepatology (Baltimore, Md.) 1997;25(3):740-4.
-
1997: Seifried E; Bialleck H; Weber H; Kirchmaier C M; Waschk E; Marx S; Tschauder S; Roth W K
[Prevalence of hepatitis G virus genome in blood donors]
Beiträge zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine 1997;34():11-5.
-
1996: Zeuzem S; Franke A; Lee J H; Herrmann G; Ruster B; Roth W K
Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology.
Hepatology (Baltimore, Md.) 1996;24(5):1003-9.
-
1996: Raedle J; Oremek G; Welker M; Roth W K; Caspary W F; Zeuzem S
p53 autoantibodies in patients with pancreatitis and pancreatic carcinoma.
Pancreas 1996;13(3):241-6.
-
1996: Zeuzem S; Scheuermann E H; Waschk D; Lee J H; Blaser C; Franke A; Roth W K
Phylogenetic analysis of hepatitis C virus isolates from hemodialysis patients.
Kidney international 1996;49(3):896-902.
-
1996: Roth W K; Lee J H; Rüster B; Zeuzem S
Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays.
Journal of clinical microbiology 1996;34(2):261-4.
-
1996: Rüster B; Zeuzem S; Roth W K
Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma.
Biochemical and biophysical research communications 1996;219(3):911-5.
-
1996: Zeuzem S; Schmidt J M; Lee J H; Rüster B; Roth W K
Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo.
Hepatology (Baltimore, Md.) 1996;23(2):366-71.
-
1996: Zeuzem S; Teuber G; Lee J H; Rüster B; Roth W K
Risk factors for the transmission of hepatitis C.
Journal of hepatology 1996;24(2 Suppl):3-10.
-
1995: Zeuzem S; Ruster B; Lee J H; Stripf T; Roth W K
Evaluation of a reverse hybridization assay for genotyping of hepatitis C virus.
Journal of hepatology 1995;23(6):654-61.
-
1995: Raedle J; Roth W K; Oremek G; Caspary W F; Zeuzem S
Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
Digestive diseases and sciences 1995;40(12):2587-94.
-
1995: Zeuzem S; Roth W K; Herrmann G
[Viral hepatitis C]
Zeitschrift für Gastroenterologie 1995;33(2):117-32.
-
1995: Rüster B; Zeuzem S; Roth W K
Quantification of hepatitis C virus RNA by competitive reverse transcription and polymerase chain reaction using a modified hepatitis C virus RNA transcript.
Analytical biochemistry 1995;224(2):597-600.
-
1994: Zeuzem S; Rüster B; Roth W K
Clinical evaluation of a new polymerase chain reaction assay (Amplicor HCV) for detection of hepatitis C virus.
Zeitschrift für Gastroenterologie 1994;32(6):342-7.
Sign-in to see more
